About
Navigating the complicated world of coding, coverage and payment for medical devices is a daunting task for even the most successful and experienced reimbursement executive. However, mastery of these processes is necessary for the successful commercialization of medical technologies today.
Integrate reimbursement tactics throughout the product life cycle to secure pre-launch coverage
With sophisticated payors now demanding very specific clinical evidence and economic data to support favorable coverage decisions, it has become imperative that device companies address reimbursement issues as early in the planning process as possible. Device manufacturers must devise and implement a coordinated regulatory-reimbursement plan in order to increase the likelihood of coverage and — ultimately — improve market success.
American Conference Institute has developed this publication from its premiere In-House Counsel Forum on Government Regulation of Medical Device Pricing & Reimbursement to provide reimbursement teams with the most up-to-date and comprehensive information, as well as effective strategies for tackling the most complicated medical device pricing and reimbursement challenges.
About
Navigating the complicated world of coding, coverage and payment for medical devices is a daunting task for even the most successful and experienced reimbursement executive. However, mastery of these processes is necessary for the successful commercialization of medical technologies today.
Integrate reimbursement tactics throughout the product life cycle to secure pre-launch coverage
With sophisticated payors now demanding very specific clinical evidence and economic data to support favorable coverage decisions, it has become imperative that device companies address reimbursement issues as early in the planning process as possible. Device manufacturers must devise and implement a coordinated regulatory-reimbursement plan in order to increase the likelihood of coverage and — ultimately — improve market success.
American Conference Institute has developed this publication from its premiere In-House Counsel Forum on Government Regulation of Medical Device Pricing & Reimbursement to provide reimbursement teams with the most up-to-date and comprehensive information, as well as effective strategies for tackling the most complicated medical device pricing and reimbursement challenges.
Contents & Contributors
ASSESSING THE IMPACT OF THE CHANGE IN CONGRESSIONAL
LEADERSHIP ON MEDICAL DEVICE PRICING AND REIMBURSEMENT
Kathy E. Means, Arnold & Porter LLP
DEMYSTIFYING THE CODING AND PAYMENT LABYRINTH
Allison Weber Shuren, Arent Fox LLP
APPROVAL AND REIMBURSEMENT STRATEGIES FOR
NEW MEDICAL TECHNOLOGIES
Peter M. Kazon, Alston & Bird, LLP
PREPARING FOR THE RIPPLE EFFECT: PRICING TRANSPARENCY AND
THE MEDICAL DEVICE INDUSTRY
Leland Chait, McGuire Woods LLP
GRAPPLING WITH THE REIMBURSEMENT IMPLICATIONS ASSOCIATED
WITH OFF-LABEL USES OF MEDICAL DEVICES
Thomas S. Crane, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
THE IMPACT OF MEDICARE ON PRIVATE PAYERS
Jim Garver, Allergan Medical Health
Publication Details